Accel Therapies — 2 certified H-1B filings (FY2026)
- 2
- Filings · FY2026
- $97k
- Median base · FY2026
- Growth and Operations Manager
- Top role · 2 all-time
- TX
- Top state · 2 all-time
Accel Therapies filed 2 certified H-1B LCAs in FY2026, with a median base salary of $97k and the middle 50% of offers between $97k and $115k. Across all years it has 2 certified filings since FY2026, most often for Growth and Operations Manager in Texas.
How much does Accel Therapies pay H-1B workers?
Certified base salary by fiscal year: each box is the p25–p75 range, the heavy line the median, the whiskers reach p10–p90. $97k median in FY2026. Base pay only — hover a year for its figures.
How has Accel Therapies's H-1B hiring changed by year?
2 certified filings on record (FY2026).
| Fiscal year | Filings | vs prior FY | Median base |
|---|---|---|---|
| FY2026 | 2 | — | $97k |
Which wage levels does Accel Therapies file?
DOL prevailing-wage levels I–IV approximate experience tiers (I = entry, IV = fully competent). 0% of Accel Therapies's filings sit at Level III–IV. A heavy I–II skew reads as entry-level or contractor-style hiring; a heavy IV skew as senior in-house roles — and higher levels earn more lottery entries.
Share of 2 filings with a wage level · all years
- Level II100.0%2
What jobs does Accel Therapies sponsor for H-1B?
The most-filed job titles across all years (DOL titles, employer pay-grade codes stripped), with base-salary percentiles.
| Job title | Filings | Median base |
|---|---|---|
| Growth and Operations Manager | 2 | $97k |
Where does Accel Therapies hire H-1B workers?
Worksite states on the certified filings, all years. Deeper pink = more filings; hover a state for its figures.
| State | Filings | Median base |
|---|---|---|
| TX | 2 | $97k |
What has Accel Therapies filed recently?
Every certified LCA on record for Accel Therapies: job title, worksite, prevailing-wage level and the offered base salary.
| FY | Job title | Base salary |
|---|---|---|
| 2026 | Growth and Operations Manager | $115,000 |
| 2026 | Growth and Operations Manager | $97,198 |
Common questions about Accel Therapies's H-1B filings
- How much does Accel Therapies pay H-1B workers?
- Accel Therapies's median certified H-1B base salary is $97k (FY2026), from 2 filings. See the full salary distribution and percentiles above.
- How many H-1B workers does Accel Therapies sponsor?
- Accel Therapies has 2 certified H-1B Labor Condition Applications on record (FY2026).
- What jobs does Accel Therapies sponsor for H-1B?
- Accel Therapies's most-sponsored H-1B roles include Growth and Operations Manager.
- Where does Accel Therapies hire H-1B workers?
- Accel Therapies's top H-1B worksite states are TX.
- Does a certified LCA mean an H-1B visa was approved?
- No. A Labor Condition Application (LCA) is the Department of Labor attestation an employer must have certified before filing an H-1B petition with USCIS. It records the job, worksite and offered wage, but not whether the petition was filed, selected in the lottery, or approved. Filing counts measure intent to sponsor, not headcount.
- What salary do these figures show?
- The base annual wage offered on the certified LCA, converted to a yearly amount. Bonus, equity, overtime and benefits are not included, so total compensation is typically higher. Figures are medians and percentiles over certified filings; wages above $5,000,000 a year are excluded as data-entry errors.
- What do prevailing-wage levels I–IV mean?
- The Department of Labor assigns each LCA an OES wage level from I (entry) to IV (fully competent) for the occupation and area. Under the FY2027 wage-weighted H-1B lottery rule, a higher level earns more selection entries, so an employer's level mix is a proxy for how senior its sponsored roles are.
Keep exploring
Calculate your H-1B lottery odds →orCheck out the insights →
Source: U.S. Department of Labor, Office of Foreign Labor Certification — certified LCA disclosure data through June 2026 (FY2026). An LCA is not an approved visa; pay figures are base salary and exclude bonus and equity. Methodology →